Continental Chemicals Limited has confirmed there is no deviation or variation in the use of funds raised through its preferential issue of ₹1.62 lakh. The entire amount allocated for working capital has been fully utilized as planned. The audit committee has reviewed and approved this status. This clarity reassures investors that funds raised are being deployed according to original objectives, supporting the company’s operational needs without any changes.